EP Patent

EP0321231B1 — Pharmaceutical compositions

Assigned to Richardson Vicks Inc · Expires 1992-03-11 · 34y expired

What this patent protects

Novel pharmaceutical compositions of matter are disclosed for use in eliciting a topical anesthetic and antimicrobial response, preferably for oral health care purposes, said compositions comprising dyclonine hydrochloride and phenol. When used in combination, dyclonine hydrochlo…

USPTO Abstract

Novel pharmaceutical compositions of matter are disclosed for use in eliciting a topical anesthetic and antimicrobial response, preferably for oral health care purposes, said compositions comprising dyclonine hydrochloride and phenol. When used in combination, dyclonine hydrochloride and phenol provide an improved antimicrobial response.

Drugs covered by this patent

levocetirizine-dihydrochloride (LEVOCETIRIZINE DIHYDROCHLORIDE)

Patent Metadata

Patent number: EP0321231B1
Jurisdiction: EP
Classification: —
Expires: 1992-03-11
Drug substance claim: No
Drug product claim: No
Assignee: Richardson Vicks Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.